TTRX
Turn Therapeutics Inc.
12.40$
-7.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 24 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 78.4% | 75.7% | 42.7% | 61.4% | 61.5% | |
| – | 73.6% | 71.4% | 41.7% | 60.2% | 60.7% | |
| – | 73.6% | 71.4% | 41.7% | 60.2% | 60.7% | |
| – | 19.1% | 20.8% | 7.6% | 4.9% | 5.4% | |
| – | 59.0% | 87.2% | 61.5% | 67.2% | 96.0% | |
| – | 24.5% | 53.1% | 49.4% | 27.5% | 51.7% | |
| – | 1.0% | 1.0% | 0.4% | 0.3% | 0.3% | |
| – | – | 52.1% | 24.1% | 12.4% | 15.4% | |
| – | – | – | – | 31.8% | 35.7% | |
| – | 41.0% | 12.8% | 38.5% | 32.8% | 4.0% | |
| – | -479.4% | -521.1% | -184.1% | -125.3% | -172.2% | |
| – | 317.3% | 644.2% | 242.1% | 158.1% | 175.6% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.